- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Nectar Lifesciences Ltd. has announced a significant update on its pending litigation involving the Department of Revenue and CGST authorities. The company’s blocked Input Tax Credit (ITC) amounting to Rs. 16.62 Cr has been unblocked by the CGST Commissioner following a favorable appeal decision. The company plans to withdraw its writ petition if the ITC remains unblocked, improving its working capital and cash flow position. This development reduces regulatory uncertainty and supports operational liquidity, which is positive for shareholders.